Lawrence will lead Galen Growth’s operations in North America — where the global Digital Health analytics company sets foot after APAC & Europe
- Lawrence brings over 20 years of Operations & Sales experience in healthcare
- Galen Growth takes its proven product & services to North America at a crucial point in Digital Health
- The development expands Galen Growth’s operations from APAC & Europe, marking the company’s global coverage
SINGAPORE/BASEL/CHICAGO, October 10, 2022: Galen Growth, the global leader in Digital Health analytics, has augmented its leadership team with the appointment of Lawrence Wurtz, who joins as General Manager – North America. The development also marks a new market entry for the company that has successfully established operations in Singapore and Switzerland. As General Manager – North America, Lawrence leads Galen Growth’s expansion in the region. He brings over 20 years of Operations & Sales experience in healthcare.
Formidable HealthTech Experience
Lawrence has worked on building high-growth healthcare technology companies and possesses a deep understanding of Digital Health startups. He has held leadership roles in prominent healthcare organisations like Labcorp, Allscripts and Scribe. He was also previously Co-founder & CEO of a healthcare technology & services company. He holds a Bachelor’s degree in Business Administration, Economics & Political Science from Illinois State University.
He joined the Galen Growth team in August 2022. Based in Chicago, he is conveniently located close to the home of major healthcare players such as Abbott and Baxter. He also has a region-wide reach that includes the East & West coasts of the US along with Canada.
“I am excited to join Galen Growth and to lead the North America expansion of a company with such a strong global presence and reputation,” said Lawrence Wurtz, General Manager – North America, Galen Growth. “We are delighted that Lawrence has joined the Galen Growth team. His 20+ years of experience in building healthcare technology firms in the United States and commercial leadership will accelerate our growth in North America, building on our fantastic track record in both the Asia Pacific and Europe,” said Julien de Salaberry, CEO & Co-founder, Galen Growth.
From APAC and Europe to North America
Galen Growth was founded in Singapore in 2016 to tap into the Digital Health momentum that was already fast-building in the Asia Pacific at the time. The world’s leading Digital Health data, intel and insights company expanded to Europe by setting up its Basel, Switzerland office in 2019. The strategic move took Galen Growth closer to the region’s life sciences hub, home to some of the largest pharma companies like Roche and Novartis.
Now, it enters North America to take its proven product and market fit to the world’s largest VC market by funding deployed and healthcare spend. Once again, the company makes the move at an opportune moment when the global Digital Health ecosystem’s maturity is at an inflection point. While Galen Growth has been working with several clients in the region, the leadership team is excited to be closer to the action. It will enable them to continue powering the Digital Health strategy of leading healthcare companies based in North America and connect them to the most promising Digital Health ventures from around the world.
About Galen Growth
Galen Growth partners leading companies for their Digital Health market intel needs. With comprehensive data, empirical research and expert insights, the company helps global organisations reach the optimal solution for their business transformation, discover the latest trends in Digital Health and strengthen their innovative know-how. HealthTech Alpha, Galen Growth’s proprietary platform for Private Market Data for Digital Health, transforms how leaders and corporations make Digital Health decisions.
To learn more about Galen Growth, visit www.galengrowth.com
To experience HealthTech Alpha, visit www.healthtechalpha.com
For the latest updates in Digital Health, follow Galen Growth on social media: